Veri

Founded 2019
Employees 45+
Primary contact
Kaikukatu 4
00530 Helsinki
Finland
Veri has developed a blood sugar monitoring app and a tiny CGM (continuous glucose monitoring) device to make people understand and stabilize their blood sugar levels. Said CGM device is worn on the arm, is barely noticeable, painless, and lasts 14 days — all while sending the relevant data to the Veri platform. Then, Veri leverages the power of data to provide personalized insights to help you achieve optimal metabolic health, reach your health goals, and extend your health span.
Founded 2019
Employees 45+
Primary contact
Kaikukatu 4
00530 Helsinki
Finland

Funding 💰

Total €10.8M
Select investors Lifeline Ventures, PROfounders Capital, Accel

Key people 🧑‍🤝‍🧑

Highlights

  • Solving the problem: There has been an explosion of interest in glucose monitoring for non-diabetics in the past two years. And there's a good reason: 93% of Americans are metabolically unhealthy, and the numbers aren't much better for the rest of the world. But only 10% of that unhealthy population is considered type 2 diabetic. That's because metabolic health is a spectrum, not a binary between diabetic and non-diabetic. And it's hard to understand where you are on that spectrum and how to improve. 🔗
  • Integrated metrics: Veri's metric integrates five evidence-based metrics shown to have the biggest impact on your healthspan - average glucose, morning fasting glucose, glucose variability, glucose oscillation, and body mass index (BMI).
  • Expert-based tech: Metabolic Healthspan was co-developed with Veri's advisors of researchers, endocrinologists, and cardiologists from universities like Stanford and Harvard and institutions such as the American Diabetes Association (ADA) and Centers for Disease Control and Prevention (CDC).

Video ▶️

Last update: May 23, 2023